Gilead and Novo plot next steps after trial data from NASH combo Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage ...

Over half of the world's population now lives in cities, a figure expected to rise to nearly 70% by 2050, posing significant challenges for jobs, housing, and infrastructure. The World Bank is ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...